[Biological monitoring of antithrombosis treatments (author's transl)].
D000990:Antithrombin III / Q000032:analysis; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006470:Hemorrhage / Q000517:prevention & control*; D006493:Heparin / Q000009:adverse effects; D006801:Humans
D005343:Fibrinolytic Agents; D000990:Antithrombin III; D006493:Heparin
Surveillance biologique des traitements antithrombotiques.